Stuttgart
15.04.26 | 15:46
26,340 Euro
+3,46 % +0,880
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 26,260 | 27,280 | 16:56 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.04. | Xvivo Perfusion AB (publ) GAAP EPS of SEK 0.80, revenue of SEK 812.2M | 4 | Seeking Alpha | ||
| 01.04. | XVIVO Perfusion AB: Annual Report 2025 | 188 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / April 1, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Today XVIVO Perfusion AB (publ) publish the Annual Report for 2025. The Annual Report is attached... ► Artikel lesen | |
| 19.03. | Notice To Attend the Annual General Meeting in XVIVO Perfusion Ab | 257 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / March 19, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - (the "Company"), reg. no. 556561-0424, with its registered office in Mölndal, gives notice of... ► Artikel lesen | |
| XVIVO PERFUSION Aktie jetzt für 0€ handeln | |||||
| 20.02. | XVIVO Perfusion AB: The Nomination Committee's Proposal for New Board Members | 1.589 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / February 20, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Correction: In the press release that was distributed today at 2:00 p.m. CET, the nomination... ► Artikel lesen | |
| 19.02. | XVIVO Perfusion AB: Management Change at XVIVO - CFO Transitions to New Role | 337 | ACCESS Newswire | GOTHENBURG, SWEDEN / ACCESS Newswire / February 19, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - XVIVO Perfusion AB (publ) today announces that the company's CFO, Kristoffer Nordström... ► Artikel lesen | |
| 10.02. | XVIVO Perfusion AB: Change of Date for Publication of the Interim Report January-March 2026 | 282 | ACCESS Newswire | GOTHENBURG, SWEDEN / ACCESS Newswire / February 10, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)XVIVO Perfusion AB (publ) has decided to postpone the publication of its interim report for... ► Artikel lesen | |
| 27.01. | XVIVO Perfusion AB: Year-End Report 2025 | 358 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / January 27, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)Fourth quarter 2025 (Oct-Dec)Net sales amounted to SEK 226.1 million (227.6), corresponding to... ► Artikel lesen | |
| 15.01. | XVIVO Perfusion AB: Conference Call on Year-End Report 2025 | 314 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / January 15, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Invitation to attend XVIVO's conference call regarding the presentation of the Year-end Report... ► Artikel lesen | |
| 06.01. | XVIVO Perfusion AB: XVIVO's CEO to present at J.P. Morgan's 44th Annual Healthcare Conference in San Francisco | 293 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / January 6, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Today, XVIVO announced its participation in the 44th annual J.P. Morgan Healthcare Conference... ► Artikel lesen | |
| 23.10.25 | XVIVO Perfusion AB: Interim Report January-September 2025 | 347 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / October 23, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)Third quarter 2025 (Jul-Sep)Net sales amounted to SEK 189.1 million (198.5), corresponding to growth... ► Artikel lesen | |
| 13.10.25 | XVIVO Perfusion AB: Conference Call on Interim Report July-September 2025 | 400 | ACCESS Newswire | GOTHENBURG, SWEDEN / ACCESS Newswire / October 13, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Invitation to attend XVIVO's conference call regarding the interim report July-September... ► Artikel lesen | |
| 05.09.25 | Nomination Committee of XVIVO Perfusion AB | 342 | ACCESS Newswire | GOTHENBURG, SWEDEN / ACCESS Newswire / September 5, 2025 / The following members have been appointed to XVIVO Perfusion's (STO:XVIVO)(LSE:0RKL)(FRA:3XV) nomination committee for the 2026 annual general... ► Artikel lesen | |
| 28.07.25 | XVIVO Perfusion AB: Delay in CE Approval for XVIVO's Perfusion Solution for Heart Preservation | 735 | ACCESS Newswire | GOTHENBURG, SWEDEN / ACCESS Newswire / July 28, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV). The XVIVO Heart Assist Transport and the XVIVO Heart Assist Transport Perfusion Set have received... ► Artikel lesen | |
| 21.07.25 | XVIVO Perfusion AB: First Patient Enrolled in US PRESERVE CAP Study for XVIVO Heart Assist Transport Device | 401 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / July 21, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Today, XVIVO announces that the first patient has been enrolled as part of the Continued Access... ► Artikel lesen | |
| 11.07.25 | XVIVO Perfusion AB: Interim Report January-June 2025 | 490 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / July 11, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)A quarter showing a mixed pictureSecond quarter 2025 (Apr-Jun)• Net sales amounted to SEK 178.3 million... ► Artikel lesen | |
| 10.07.25 | XVIVO Perfusion AB: Conference Call on Interim Report April-June 2025 | 476 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / July 10, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Invitation to attend XVIVO's conference call regarding the interim report April-June 2025. The... ► Artikel lesen | |
| 13.06.25 | XVIVO Perfusion AB: XVIVO Honored with 2025 SACC-USA Business Award for Life-Saving Innovation and Growth in the U.S. Market | 403 | ACCESS Newswire | GOTHENBURG, SWEDEN / ACCESS Newswire / June 13, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Yesterday, XVIVO received the prestigious Swedish American Chamber of Commerce USA (SACC-USA)... ► Artikel lesen | |
| 29.04.25 | XVIVO Perfusion AB: XVIVO Presents 12-Month Follow-Up Results from European Multicenter Heart Transplantation Trial at ISHLT in Boston | 423 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / April 29, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - The 12-month follow-up results from XVIVO's European multicenter heart trial, NIHP2019, was presented... ► Artikel lesen | |
| 25.04.25 | Bulletin from Annual General Meeting in XVIVO Perfusion AB | 542 | ACCESS Newswire | GOTHENBURG, SWEDEN / ACCESS Newswire / April 25, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)The following resolutions were passed at the Annual General Meeting (the "AGM") of XVIVO Perfusion... ► Artikel lesen | |
| 24.04.25 | XVIVO Perfusion AB: Interim Report January-March 2025 | 392 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / April 24, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)First quarter 2025 (Jan-Mar)Net sales increased to SEK 218.6 million (186.0), corresponding to growth... ► Artikel lesen |
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CARL ZEISS MEDITEC | 27,380 | +1,03 % | Shortseller-Positionen aktuell: u.a. Carl Zeiss Meditec, Evonik, FMC, Gerresheimer, GFT, MTU, Nordex, Ströer | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| ECKERT & ZIEGLER | 15,650 | -0,32 % | Eckert & Ziegler erhält MDR-Zertifizierung für Augentumorbehandlung | Die Eckert & Ziegler BEBIG GmbH, eine auf Brachytherapie spezialisierte Tochtergesellschaft der Eckert & Ziegler SE, hat die MDR-Zertifizierung der EU für ihre Ruthenium-106-Augenapplikatoren erhalten.... ► Artikel lesen | |
| UNITEDHEALTH | 264,40 | -0,83 % | UnitedHealth Group-Aktie mit +9% - Ist die Trendwende gelungen? | Nachdem der Kurs der UnitedHealth Group-Aktie zuletzt unter Druck geraten war und eine Korrekturphase durchlaufen hatte, zeigt sich nun eine Gegenbewegung. Die Erholung bringt neues Momentum in den... ► Artikel lesen | |
| INTUITIVE SURGICAL | 398,35 | +0,53 % | The Silver Tsunami Is Here -- and Intuitive Surgical Could Be the Biggest Winner | ||
| RHOEN-KLINIKUM | 12,200 | -1,61 % | Kardiologie am RHÖN-KLINIKUM Campus Bad Neustadt: Über 300 Publikationen seit 2000- Forschung für moderne Herzmedizin wird kontinuierlich ausgebaut | Bad Neustadt a.d. Saale (ots) - Die Klinik für Kardiologie am RHÖN-KLINIKUM Campus Bad Neustadt (https://www.campus-nes.de/medizin-pflege/unsere-kliniken/kardiologie/willkommen-in-der-klinik-fuer-kardiologie.html)... ► Artikel lesen | |
| HIMS & HERS HEALTH | 18,490 | +1,93 % | Hims & Hers-Aktie: Neue Chancen nach dem Hype? | Die Aktie von Hims & Hers Health hat nach einer Zeit voller Hype und überschwänglichen Erwartungen in den vergangenen Monaten massiv gelitten. Nach einem deutlichen Kursrückgang rückt nun die Frage... ► Artikel lesen | |
| BICO GROUP | 1,844 | -0,75 % | BICO Group AB: BICO Group AB has divested the Finnish property for a total of EUR 3.5m | BICO Group AB ("BICO") has completed the divestment of its property in Oulu, Finland, through the sale of BICO Real Estate Oy to Logistea AB ("Logistea"). The total sales price amounts to EUR 3.5m,... ► Artikel lesen | |
| M1 KLINIKEN | 15,000 | -0,40 % | M1 Kliniken schließt Verkauf von Haemato Pharm ab | Die M1 Kliniken AG hat den Verkauf der Haemato Pharm GmbH über ihre Mehrheitsbeteiligung Haemato AG an die Phoenix Group mit Wirkung zum Ablauf des 31. Januar 2026 abgeschlossen. Sämtliche Vollzugsbedingungen... ► Artikel lesen | |
| BAXTER | 15,080 | +1,04 % | Baxter CFO Joel Grade To Leave; Appoints Anita Zielinski As Interim CFO; Reiterates FY26 Outloook | DEERFIELD (dpa-AFX) - Healthcare company Baxter International, Inc. (BAX) announced Monday the departure of executive vice president and chief financial officer (CFO) Joel Grade, who joined... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | GlobalLogic, Asensus ink surgical robotics engineering collab | ||
| JD HEALTH INTERNATIONAL | 5,188 | -1,22 % | HSI Weakens on Thinner Turnover; Auto Stocks Rally; JD Health Slumps Over 9% | ||
| LIFEWARD | 6,530 | 0,00 % | Lifeward Ltd.: Lifeward Successfully Closes on Strategic Partnership with Oramed | HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 25, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform... ► Artikel lesen | |
| COOPER COMPANIES | 59,44 | -2,11 % | Cooper Companies: Aktionäre wählen Direktoren und genehmigen Anträge auf Jährlicher Hauptversammlung | ||
| SURGICAL SCIENCE SWEDEN | 3,244 | +3,25 % | Surgical Science Sweden AB: Year-end report 2025: Profitability in line with financial targets | Fourth quarter 2025 (October - December)Net sales amounted to SEK 268.9 (251.5) million, an increase of 7 percent compared with the corresponding period in the preceding year. Calculated in local currencies... ► Artikel lesen | |
| ONWARD MEDICAL | 3,120 | +2,13 % | ONWARD Medical NV: ONWARD Medical Publishes Convocation of the 2026 Annual General Meeting of Shareholders and Proposed Resolutions | EINDHOVEN, the Netherlands, April 01, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD - US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function... ► Artikel lesen |
XVIVO PERFUSION AB gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +3,46 % bei einem Aktienkurs von 26,340 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu XVIVO PERFUSION AB finden Sie auf Wallstreet Online.